Q-omics provides the consensus-scored DNM1P30 profile across patient tissues and cancer cell-line models. DNM1P30 expression is associated with patient survival in 7 of 34 cancer types, with the highest sampling consensus in STAD. Additionally, DNM1P30 RNA expression shows 4,677 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight STAD as cancer lineages where DNM1P30 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for DNM1P30 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes DNM1P30 survival associations across molecular data types. DNM1P30 RNA expression shows survival associations in the most cancer types (7), followed by mutation status (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

DNM1P30 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	7	STAD (126)	view →
Mutation	Kaplan–Meier	1	UCEC (36)	view →

This table ranks reproducible DNM1P30 RNA expression–survival associations across cancer types. High DNM1P30 expression shows unfavorable associations in STAD, KIRP, THCA, READ, DLBC and LUSC. The STAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .005). Together, the overview and detailed table identify STAD as the clearest survival context for DNM1P30 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.188	0.385	.005	126	view →
KIRP	OS	Tertile	II,III,IV	0.127	0.859	<.001	93	view →
THCA	DFS	Tertile	All	0.496	0.833	<.001	81	view →
READ	OS	Tertile	All	0.164	0.660	<.001	63	view →
DLBC	DFS	Tertile	II,III,IV	0.022	0.837	<.001	36	view →
LUSC	DFS	Tertile	II,III,IV	0.135	0.663	.015	18	view →

Pink = unfavorable, green = favorable. all 7 lineages →

DNM1P30-STAD (DFS)

Kaplan–Meier survival curve for DNM1P30 RNA expression in STAD: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with DNM1P30 in patient tissues and cancer cell lines. In patient samples, DNM1P30 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	4,677	STAD (4037)	view →
RNA	2,932	LGG (871)	view →